Stiefel Laboratories

Stiefel Laboratories has appointed Jim Loerop to the position of vice president of corporate development and has named Alfonso Ugarte vice president global marketing.

Mr. Loerop will be responsible for identifying, negotiating and implementing commercially viable new business opportunities, acquisitions and divestitures. He will also develop strategic partnerships and new business affairs that deliver innovation in the form of products, alliances, new technology or services.

“Jim is a tremendous asset to the Stiefel organization,” said Bill Humphries, senior vice president, commercial operations, Stiefel Laboratories. “Our growth will be exponentially magnified by the addition of Jim’s noteworthy corporate development expertise.”

Mr. Loerop’s career spans positions at Solvay Pharmaceuticals, Curatek Pharmaceuticals and IMS Health. Most recently he served as the vice president of corporate development and business expansion at KV Pharmaceutical Co. in St. Louis, MO.

Mr. Ugarte will be responsible for building the global marketing function at Stiefel and supporting its commercial efforts in more than 100 countries around the world. He will also lead the strategy, planning and execution of tactics to support and attain global sales goals.

“We are pleased that Alfonso has joined our company as he brings a wealth of marketing, sales and international skills and experience to this newly created position,” said Mr. Humphries. “Alfonso’s background in the international pharmaceutical industry will be immeasurably beneficial to our team.”

Mr. Ugarte began his 15-year career at Eli Lilly as a sales representative, then moved to Warner-Lambert as a regional marketing manager, and most recently spent nine years in various positions of increased responsibility with Merck in Colombia, Peru and the company’s world headquarters in NJ.